Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-051054

Chief Executive Officer sold 20,000 shares at $28.25 ($565,000)

From the SEC's structured data for this filing

Trades in this filing

Anzalone Christopher Richard · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-09-25 Sale : show line 1 in the form −20,000 $28.25 $565,000 2,121,903 D
Open-market sales · 20,000 sh · avg $28.25 · $565,000
Loading xslF345X03/doc4.xml…